Vir Biotechnology, Inc. (VIR)
11.70
+0.58
(+5.22%)
USD |
NASDAQ |
Oct 09, 16:00
11.70
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Price : 11.70 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 11.11 | 12.00 | 10.97 | 11.70 | 1.965M |
| Oct 08, 2026 | 11.52 | 11.56 | 10.73 | 11.12 | 3.071M |
| Oct 07, 2026 | 11.32 | 11.76 | 11.32 | 11.52 | 3.562M |
| Oct 06, 2026 | 11.90 | 11.90 | 11.25 | 11.60 | 2.587M |
| Oct 05, 2026 | 11.17 | 11.87 | 10.92 | 11.78 | 3.147M |
| Oct 02, 2026 | 11.55 | 11.73 | 10.95 | 11.17 | 2.181M |
| Oct 01, 2026 | 10.86 | 11.61 | 10.86 | 11.29 | 2.576M |
| Sep 30, 2026 | 10.70 | 11.26 | 10.54 | 11.18 | 1.738M |
| Sep 29, 2026 | 10.49 | 10.84 | 10.34 | 10.65 | 1.574M |
| Sep 28, 2026 | 10.56 | 10.69 | 10.33 | 10.51 | 1.370M |
| Sep 25, 2026 | 10.82 | 10.82 | 10.48 | 10.66 | 1.126M |
| Sep 24, 2026 | 11.02 | 11.16 | 10.35 | 10.72 | 2.085M |
| Sep 23, 2026 | 11.44 | 11.53 | 10.85 | 11.09 | 1.685M |
| Sep 22, 2026 | 10.99 | 11.72 | 10.88 | 11.50 | 1.853M |
| Sep 21, 2026 | 10.77 | 10.94 | 10.66 | 10.88 | 1.455M |
| Sep 18, 2026 | 10.92 | 11.00 | 10.44 | 10.60 | 7.017M |
| Sep 17, 2026 | 10.87 | 11.20 | 10.68 | 10.92 | 1.794M |
| Sep 16, 2026 | 10.54 | 10.67 | 10.39 | 10.52 | 2.091M |
| Sep 15, 2026 | 10.71 | 10.72 | 10.23 | 10.44 | 2.285M |
| Sep 14, 2026 | 10.73 | 10.94 | 10.64 | 10.76 | 1.842M |
| Sep 11, 2026 | 10.79 | 10.95 | 10.38 | 10.62 | 2.078M |
| Sep 10, 2026 | 10.57 | 10.78 | 10.45 | 10.58 | 1.855M |
| Sep 09, 2026 | 11.04 | 11.38 | 10.74 | 10.81 | 1.946M |
| Sep 08, 2026 | 11.22 | 11.28 | 10.99 | 11.18 | 1.614M |
| Sep 04, 2026 | 11.31 | 11.64 | 11.18 | 11.38 | 1.152M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 225.00 |
| Vaxcyte, Inc. | 71.38 |
| Caribou Biosciences, Inc. | 0.4602 |
| Arrowhead Pharmaceuticals, Inc. | 62.75 |
| Oncolytics Biotech, Inc. | 0.557 |
Price Related Metrics
| PS Ratio | 5.734 |
| Price to Book Value | 2.015 |
| Earnings Yield | -15.91% |
| Market Cap | 1.979B |